SCHEMBL18273083

SCHEMBL18273083

c1ccc(-c2ccc(-c3cccc(-c4cccc(-c5nc(-c6cccc7c6oc6ccccc67)c6sc7ccccc7c6n5)c4)c3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.40
▸ MAPT P10636 5/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ TSHR P16473 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ PIM1 P11309 2/20 0.34
▸ PIM3 Q86V86 2/20 0.34
▸ PIM2 Q9P1W9 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CSNK2A2 P19784 1/20 0.34
▸ CSNK2B P67870 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ LIMK1 P53667 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ GGPS1 O95749 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PLA2G2A P14555 1/20 0.33
▸ PLA2G4A P47712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18273102 0.99 ALOX5 (0.38) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL18273100 0.98 ALOX5 (0.37) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL18273082 0.94 ALOX5 (0.41) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL18273115 0.94 ALOX5 (0.41) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL22330026 0.93 PIM1 (0.37) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL22195926 0.93 PIM1 (0.37) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL22329396 0.93 PRKDC (0.36) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL22195602 0.93 PRKDC (0.36) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL18273125 0.93 ALOX5 (0.41) ALOX5MAPTALDH1A1TSHRPOLB
SCHEMBL18269987 0.93 ALOX5 (0.41) ALOX5MAPTALDH1A1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172061-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20230172061-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-06-01 — — US disclosed
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 1855/4885MAPT 1162/4885ALDH1A1 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback